Clinic
Fairview Clinics
Fairview Clinics was paid $8.06M by Medicaid between Jan 2018 and Dec 2024, across 154 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 29% of everything it billed.
33Billing provider infoFAIRVIEW CLINICS
BROOKLYN PARK, MN 55443
BROOKLYN PARK, MN 55443
33aNPI1679754998assigned 11/15/2007
33bProvider typeMulti-Specialty Clinic/Center
28Total paid$8.06M
24GClaims275,287
24DCodes billed154
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Multi-Specialty Clinic/Center providers in Minnesota
Rank by total paid#13 of 87
Median peer was paid$1.04M
This provider vs. median7.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official RING, MAUREEN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 45,877 | $297K | |
| 2019 | 44,009 | $1.27M | |
| 2020 | 31,994 | $1.05M | |
| 2021 | 51,910 | $1.81M | |
| 2022 | 43,079 | $1.54M | |
| 2023 | 32,473 | $1.12M | |
| 2024incomplete | 25,945 | $977K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 29% | 35,400 | 32,184 | $2.35M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 23% | 38,615 | 35,974 | $1.88M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 7.2% | 7,826 | 7,511 | $583K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 5.9% | 8,267 | 8,157 | $475K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3.9% | 4,713 | 4,571 | $316K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.7% | 3,140 | 3,108 | $218K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1.9% | 6,630 | 6,380 | $155K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.8% | 2,379 | 2,268 | $149K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.7% | 2,014 | 2,000 | $137K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.6% | 4,036 | 3,952 | $132K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.6% | 11,916 | 11,647 | $130K |
| 36415 | Collection of venous blood by venipuncture | 1.1% | 27,379 | 25,065 | $93K |
142 more codes
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.1% | 3,272 | $91K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 1.1% | 5,570 | $85K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 981 | $71K |
| 80061 | Lipid panel | <1% | 4,523 | $51K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 720 | $49K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,719 | $48K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,702 | $47K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 401 | $41K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 475 | $39K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 3,496 | $39K |
| 99188 | <1% | 4,854 | $36K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 4,627 | $35K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 341 | $34K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,997 | $33K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 5,034 | $31K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,262 | $30K |
| 92551 | <1% | 4,837 | $29K | |
| 80053 | Comprehensive metabolic panel | <1% | 3,655 | $28K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,240 | $27K |
| 91320 | <1% | 349 | $26K | |
| X5622 | <1% | 2,013 | $26K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,384 | $25K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,632 | $21K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 499 | $20K |
| 96127 | <1% | 5,713 | $20K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,865 | $20K |
| 90686 | <1% | 4,790 | $18K | |
| 90662 | <1% | 482 | $17K | |
| 99000 | <1% | 1,274 | $15K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 280 | $14K |
| 80050 | General health panel | <1% | 312 | $14K |
| 90480 | <1% | 477 | $13K | |
| 85027 | <1% | 2,616 | $13K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 283 | $13K |
| 0001A | <1% | 312 | $13K | |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | <1% | 862 | $12K |
| 87081 | <1% | 2,494 | $12K | |
| 0054A | <1% | 301 | $12K | |
| 87210 | <1% | 2,447 | $11K | |
| 0002A | <1% | 258 | $10K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,433 | $9K |
| 90651 | <1% | 545 | $9K | |
| 81001 | <1% | 3,482 | $9K | |
| 81025 | <1% | 1,067 | $9K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 161 | $9K |
| 86803 | <1% | 696 | $8K | |
| 90682 | <1% | 183 | $8K | |
| 0072A | <1% | 215 | $8K | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | <1% | 424 | $8K |
| 86780 | <1% | 720 | $7K | |
| 82728 | <1% | 638 | $7K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 114 | $7K |
| 82043 | <1% | 1,361 | $7K | |
| 0071A | <1% | 171 | $6K | |
| 99173 | <1% | 5,201 | $6K | |
| 90715 | <1% | 621 | $6K | |
| 92015 | Determination of refractive state | <1% | 924 | $6K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 215 | $6K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 699 | $5K |
| 90670 | <1% | 1,796 | $5K | |
| G0008 | Administration of influenza virus vaccine | <1% | 682 | $5K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 106 | $5K |
| 99442 | <1% | 218 | $5K | |
| 0124A | <1% | 147 | $5K | |
| 0004A | <1% | 169 | $5K | |
| 93000 | <1% | 595 | $4K | |
| 0064A | <1% | 119 | $4K | |
| 99421 | <1% | 685 | $4K | |
| T1013 | Sign language or oral interpretive services, per 15 minutes | <1% | 85 | $4K |
| 90473 | <1% | 351 | $4K | |
| 84439 | <1% | 486 | $4K | |
| 99441 | <1% | 259 | $3K | |
| 90750 | <1% | 25 | $3K | |
| 83655 | <1% | 361 | $3K | |
| 99397 | <1% | 26 | $3K | |
| 0052A | <1% | 66 | $3K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 83 | $3K |
| 87340 | <1% | 389 | $3K | |
| 36416 | <1% | 900 | $2K | |
| 87807 | <1% | 190 | $2K | |
| 85610 | <1% | 725 | $2K | |
| 80197 | <1% | 213 | $2K | |
| 99443 | <1% | 70 | $2K | |
| 87186 | <1% | 294 | $2K | |
| 0154A | <1% | 49 | $2K | |
| 82947 | <1% | 674 | $2K | |
| 0051A | <1% | 40 | $2K | |
| G0476 | Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test | <1% | 156 | $2K |
| 85018 | <1% | 889 | $2K | |
| 0082A | <1% | 35 | $1K | |
| 0134A | <1% | 35 | $1K | |
| 90656 | <1% | 335 | $1K | |
| 99381 | <1% | 12 | $1K | |
| 99384 | <1% | 13 | $980.69 | |
| 84703 | <1% | 515 | $955.48 | |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | <1% | 40 | $840.83 |
| 81003 | <1% | 517 | $827.89 | |
| 96161 | <1% | 417 | $762.40 | |
| 0083A | <1% | 18 | $706.97 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 248 | $681.64 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 99 | $578.49 |
| 82607 | <1% | 39 | $558.85 | |
| 90474 | <1% | 118 | $539.16 | |
| 0081A | <1% | 13 | $525.18 | |
| 74019 | <1% | 41 | $461.11 | |
| 84460 | <1% | 94 | $430.73 | |
| 86140 | <1% | 101 | $362.13 | |
| V2020 | Frames, purchases | <1% | 12 | $360.00 |
| 90734 | <1% | 355 | $346.80 | |
| 82248 | <1% | 63 | $259.08 | |
| 87088 | <1% | 41 | $253.41 | |
| 73610 | <1% | 12 | $245.36 | |
| 73630 | <1% | 14 | $239.52 | |
| 85652 | <1% | 137 | $237.30 | |
| 83550 | <1% | 26 | $229.37 | |
| 90716 | <1% | 137 | $208.90 | |
| 69209 | <1% | 14 | $201.83 | |
| 90707 | <1% | 107 | $121.13 | |
| 90698 | <1% | 1,194 | $105.87 | |
| 83721 | <1% | 14 | $96.88 | |
| 83690 | <1% | 12 | $87.36 | |
| 82565 | <1% | 12 | $69.18 | |
| 90744 | <1% | 708 | $29.28 | |
| 92341 | <1% | 53 | $27.84 | |
| 90677 | <1% | 135 | $15.00 | |
| 90697 | <1% | 61 | $15.00 | |
| 90680 | <1% | 382 | $15.00 | |
| 90696 | <1% | 115 | $12.38 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 48 | $3.21 |
| 82570 | <1% | 144 | $1.26 | |
| 91317 | <1% | 14 | $0.02 | |
| 90619 | 0% | 14 | $0.00 | |
| 91319 | 0% | 12 | $0.00 | |
| 90710 | 0% | 78 | $0.00 | |
| 90633 | 0% | 798 | $0.00 | |
| 90685 | 0% | 222 | $0.00 | |
| 90648 | 0% | 38 | $0.00 | |
| 87338 | 0% | 12 | $0.00 | |
| 90700 | 0% | 55 | $0.00 | |
| 82274 | 0% | 27 | $0.00 | |
| 90681 | 0% | 135 | $0.00 | |
| 80076 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRING, MAUREEN (SYS DIR GOVT REIMB & NETWK REL)
| Provider | Location | Paid |
|---|---|---|
| Fairview Health Services | Minneapolis, MN | $90.41M |
| Fairview Health Services | Saint Paul, MN | $48.52M |
| Fairview Health Services | Burnsville, MN | $29.98M |
| Fairview Health Services | Minneapolis, MN | $26.56M |
| Healtheast ST. John's Hospital | Maplewood, MN | $17.91M |
| Fairview Health Services | Edina, MN | $17.24M |
| Healtheast Medical Research Institute | Saint Paul, MN | $11.37M |
| Fairview Clinics | Bloomington, MN | $9.40M |
| Fairview Health Services | Princeton, MN | $9.36M |
| Healtheast Medical Research Institute | Saint Paul, MN | $8.76M |
| Healtheast Medical Research Institute | Saint Paul, MN | $8.29M |
| Fairview Health Services | Wyoming, MN | $7.71M |
| Healtheast Medical Research Institute | Maplewood, MN | $7.44M |
| Healtheast Woodwinds Hospital | Woodbury, MN | $6.17M |
| Fairview Clinics | Burnsville, MN | $4.75M |
| Fairview Clinics | Minneapolis, MN | $4.75M |
| Fairview Express Care | Saint Paul, MN | $4.57M |
| Fairview Clinics | Saint Paul, MN | $4.37M |
| Healtheast Medical Research Institute | Woodbury, MN | $4.07M |
| Fairview Clinics | Princeton, MN | $4.05M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.